Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 3 days ago
37 views
Shared 2 weeks ago
106 views
Shared 2 weeks ago
105 views
Shared 3 weeks ago
54 views
Shared 1 month ago
72 views
Shared 1 month ago
103 views
Shared 1 month ago
81 views
Shared 1 month ago
169 views
Shared 1 month ago
220 views
Shared 2 months ago
198 views
Shared 3 months ago
165 views
Shared 3 months ago
76K views
Shared 3 months ago
502 views
Shared 5 months ago
628 views
Shared 5 months ago
1K views
Shared 5 months ago
783 views
Shared 5 months ago
145K views
Shared 6 months ago
1.2K views
Shared 6 months ago
403 views
Shared 6 months ago
209K views
Shared 7 months ago
360 views
Shared 9 months ago
473K views
Shared 9 months ago
236 views
Shared 9 months ago
107 views